Terms Of Use | Privacy Policy


Gynecologic Cancers, Oklahoma TSET Phase I Program

Kathleen Moore, MD

Director, Oklahoma TSET Phase I Program; Associate Professor, Section of Gynecologic Oncology

Kathleen Moore, MD is an associate professor in the section of gynecologic oncology and serves as the director of the Oklahoma TSET Phase I Clinical Trials Program, the state’s only phase I clinical trials program. She is the Jim and Christy Everest Endowed Chair in Cancer Research as well as the director of the gynecologic oncology fellowship program. She also serves as the Associate Director of Clinical Research and Medical Director of the Clinical Trials Office for the Stephenson Cancer Center. 

Dr. Moore has published more than 200 peer-reviewed publications and serves on the editorial board for four academic publications. She has a clinical research interest in drug development and phase I trials.

She attended medical school at the University of Washington School of Medicine and completed her residency in obstetrics and gynecology at the University Health Center of Pittsburgh. Dr. Moore completed a fellowship in gynecologic oncology at the University of Oklahoma Health Sciences Center while simultaneously earning a master’s degree in epidemiology..

She is board certified in obstetrics and gynecology as well as gynecologic oncology and hospice and palliative care.


Fellowship: OU College of Medicine, Oklahoma City, OK
Residency: University Health Center of Pittsburgh, Pittsburgh, PA
Medical School: University of Washington School of Medicine, Seattle, WA

Honors and Awards:

Golden Pillar Award for Patient Satisfaction, 2011
Senior Resident Research Award, Magee-Women’s Hospital, 2004
Irene Mclenahan Young Investigators Award, 2002
The Best Medical Student Teaching Resident, University of Pittsburgh, 2002
Virginia Mason Award for Clinical Excellence, 2000

Professional Associations:

National Cancer Institute, Gynecologic Cancer Steering Committee
Gynecologic Oncology Group
Society of Gynecologic Oncology